BBVC Presents, "New Year, New Check"

​It’s a new year—time to deploy new checks! Breaking Barriers of VC (BBVC) is proud to kick off 2025 with the latest installment of our panel series: New Year, New Check.

​Join us for an insightful evening as industry leaders reflect on how the venture market evolved in 2024 and share predictions for the 2025 market outlook. Whether you're an investor, founder, or operator, this panel is your chance to gain actionable insights and network with the movers and shakers of venture capital.

​The Panel:

Laurent Span: (Moderator) GP at SPANVentures., a venture firm focused on early-stage investments through a syndicate model.

​Naomi Goez: Principal at Forum Ventures, Naomi is a former supply chain operator turned emerging thought leader and investor, dedicated to bringing more women, first-gen individuals, and immigrants to the table in the venture landscape.

​Mirit Lugassi: is an Investor at Laconia Capital, focusing on early stage b2b software companies that are transforming the way business is done. A Fintech startup operator turned venture capital investor, she has a global track record (US, Europe, Israel & UK) of transforming companies and teams in the b2b software space.

​Ankit Agarwal: Ankit Agarwal is an investor with A7V, his family office. A7V has invested in 50+ early-stage companies, and 12+ venture funds and incubated several companies. Earlier, Ankit founded and exited, Micello, a global geospatial software business.

​Ariel Rom: Ariel represents emerging tech and life sciences companies and their investors in a variety of transactions – including financings, mergers and acquisitions, company formations, spinoffs, and joint ventures. He also counsels clients on corporate governance matters and other day-to-day legal issues. In addition, Ariel frequently speaks and lectures on topics important to high-growth companies and venture capital investors at institutions such as Cornell Tech and the NYU Stern School of Business.

​Sponsored By:

​Cooley LLP: Cooley LLP is a global law firm that specializes in technology and life sciences, venture funds & early-stage companies.

​If you have recently been exposed to, are experiencing symptoms of, and/or have tested positive for COVID-19 or any other contagious illness, please refer to the Centers for Disease Control and Prevention’s respiratory virus guidance to determine if you should attend this event. Thank you for your cooperation.